Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1/2 1

Status

Completed 10Active not recruiting 4Terminated 3Recruiting 3Unknown 2Withdrawn 1No longer available 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2

Conditions

Leukemia, Myeloid, Acute 372Precursor Cell Lymphoblastic Leukemia-Lymphoma 292Leukemia 218Hematologic Neoplasms 160Leukemia, Lymphocytic, Chronic, B-Cell 129Lymphoma 107Myelodysplastic Syndromes 90Leukemia, Myelogenous, Chronic, BCR-ABL Positive 82Lymphoma, Non-Hodgkin 66Recurrence 63Lymphoma, Large B-Cell, Diffuse 50Lymphoma, Follicular 47Lymphoma, Mantle-Cell 44Multiple Myeloma 42Burkitt Lymphoma 41Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 39Leukemia, B-Cell 39Neoplasms 38Leukemia, Myeloid, Chronic-Phase 37Lymphoma, B-Cell 36Lymphoma, B-Cell, Marginal Zone 31Hodgkin Disease 29Lymphoma, Large-Cell, Immunoblastic 26Leukemia, Promyelocytic, Acute 23Leukemia, Myelomonocytic, Chronic 21Neoplasms, Plasma Cell 19Myeloproliferative Disorders 19Congenital Abnormalities 19Leukemia, Myelomonocytic, Acute 18Leukemia, Myeloid 18

Interventions

amonafide 1Daunorubicin 1Cytarabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Lymphatic Diseases × Other hematologic neoplasm × Clear all
NCT04601584 2024-03-06

GNR-084 Safety and Pharmacological Characteristics in Refractory or Relapse B-cell Precursor ALL

AO GENERIUM

Phase 1/2 Unknown
36 enrolled
LymphoidOther hematologic neoplasm

Hematologic Diseases, Immune System Diseases, Immunoproliferative Disorders, Leukemia, Leukemia, Lymphoid, Lymphatic Diseases, Lymphoproliferative Disorders, Neoplasms, Neoplasms by Histologic Type, Neoplastic Processes, Pathologic Processes, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00715637 2010-10-13

Phase III Randomized Study of Amonafide (AS1413) and Cytarabine Versus Daunorubicin and Cytarabine in Patients With Secondary Acute Myeloid Leukemia (AML)- the ACCEDE Study

Antisoma Research

Phase 3 Unknown
420 enrolled
Other hematologic neoplasm

Leukemia, Lymphatic Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡